Related references
Note: Only part of the references are listed.netmeta: An R Package for Network Meta-Analysis Using Frequentist Methods
Sara Balduzzi et al.
JOURNAL OF STATISTICAL SOFTWARE (2023)
Comparison of structural and functional outcome of aflibercept versus ranibizumab in patients with myopic choroidal neovascularization
Ahmed Howaidy et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Comparison of Efficacy of Intravitreal Ranibizumab and Aflibercept in Eyes with Myopic Choroidal Neovascularization: 24-Month Follow-Up
Andrii Korol et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2020)
The Evaluation of a Two-Year Outcome of Intravitreal Conbercept versus Ranibizumab for Pathological Myopic Choroidal Neovascularization
Cong Chen et al.
CURRENT EYE RESEARCH (2020)
RANIBIZUMAB VERSUS VERTEPORFIN PHOTODYNAMIC THERAPY IN ASIAN PATIENTS WITH MYOPIC CHOROIDAL NEOVASCULARIZATION BRILLIANCE, a 12-Month, Randomized, Double-Masked Study
Youxin Chen et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2019)
Comparison of Intravitreal Aflibercept and Ranibizumab for Treatment of Myopic Choroidal Neovascularization: One-Year Results-A Retrospective, Comparative Study
Burak Erden et al.
JOURNAL OF OPHTHALMOLOGY (2019)
Two different initial treatment regimens of ranibizumab in myopic choroidal neovascularization: 12-month results from a randomized controlled study
Songshan Li et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2019)
Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization
Kaori Sayanagi et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2019)
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Jia-Kang Wang et al.
SCIENTIFIC REPORTS (2018)
Reduced-fluence verteporfin photodynamic therapy plus ranibizumab for choroidal neovascularization in pathologic myopia
M. Rinaldi et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2017)
Long-Term Outcomes of Two Different Initial Dosing Regimens of Intravitreal Ranibizumab Used to Treat Myopic Choroidal Neovascularization
Cristina Calvo-Gonzalez et al.
OPHTHALMOLOGICA (2017)
Myopic Choroidal Neovascularization Review, Guidance, and Consensus Statement on Management
Chui Ming Gemmy Cheung et al.
OPHTHALMOLOGY (2017)
FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION
Pierluigi Iacono et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2017)
Comparison of photodynamic therapy, ranibizumab/bevacizumab or combination in the treatment of myopic choroidal neovascularisation: a 9-year-study from a single centre
Pukhraj Rishi et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2016)
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial
John A. Wells et al.
OPHTHALMOLOGY (2016)
CLINICAL OUTCOMES OF INTRAVITREAL BEVACIZUMAB VERSUS PHOTODYNAMIC THERAPY WITH OR WITHOUT BEVACIZUMAB FOR MYOPIC CHOROIDAL NEOVASCULARIZATION
Eui Chun Kang et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2016)
Rayyan-a web and mobile app for systematic reviews
Mourad Ouzzani et al.
SYSTEMATIC REVIEWS (2016)
Intravitreal Aflibercept Injection in Patients with Myopic Choroidal Neovascularization The MYRROR Study
Yasushi Ikuno et al.
OPHTHALMOLOGY (2015)
FACTORS INFLUENCING NEED FOR RETREATMENT AND LONG-TERM VISUAL OUTCOME AFTER INTRAVITREAL BEVACIZUMAB FOR MYOPIC CHOROIDAL NEOVASCULARIZATION
Danny Siu-Chun Ng et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2015)
INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR CHOROIDAL NEOVASCULARIZATION SECONDARY TO PATHOLOGIC MYOPIA Six Years Outcome
Jose M. Ruiz-Moreno et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2015)
A randomized trial of intravitreal bevacizumab vs. ranibizumab for myopic CNV
Alfredo Pece et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2015)
Anti-VEGF Therapy in Myopic Choroidal Neovascularization: Long-Term Results
Paulo Freitas-da-Costa et al.
OPHTHALMOLOGICA (2014)
RADIANCE: A Randomized Controlled Study of Ranibizumab in Patients with Choroidal Neovascularization Secondary to Pathologic Myopia
Sebastian Wolf et al.
OPHTHALMOLOGY (2014)
LONG-TERM FUNCTIONAL AND MORPHOLOGIC RETINAL CHANGES AFTER RANIBIZUMAB AND PHOTODYNAMIC THERAPY IN MYOPIC CHOROIDAL NEOVASCULARIZATION
Mariacristina Parravano et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2014)
Comparison of 1-year therapeutic effect of ranibizumab and bevacizumab for myopic choroidal neovascularization: a retrospective, multicenter, comparative study
Dong Min Cha et al.
BMC OPHTHALMOLOGY (2014)
Effects of oral bisphosphonates on myopic choroidal neovascularisation over 2 years of follow-up: comparison with anti-VEGF therapy and photodynamic therapy. A pilot study
Akiko Miki et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2013)
Intravitreal anti-VEGF therapy for choroidal neovascularisation secondary to pathological myopia: 4-year outcome
Jose M. Ruiz-Moreno et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2013)
Choroidal thickness after treatment for myopic choroidal neovascularization
Claudia L. Farinha et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2013)
Intravitreal Bevacizumab in Myopic Neovascular Membranes: 24-Month Results
Jose M. Ruiz-Moreno et al.
OPHTHALMOLOGY (2013)
INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR CHOROIDAL NEOVASCULARIZATION SECONDARY TO PATHOLOGIC MYOPIA Systematic Review and Meta-Analysis
Erqian Wang et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2013)
Three versus one intravitreal bevacizumab injections as initial protocol to treat myopic choroidal neovascularization
Jose M. Ruiz-Moreno et al.
ACTA OPHTHALMOLOGICA (2012)
Comparison between anti-vascular endothelial growth factor therapy and photodynamic therapy for myopic choroidal neovascularization
Misa Matsuo et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2012)
Spectral-domain OCT in anti-VEGF treatment of myopic choroidal neovascularization
U. Introini et al.
EYE (2012)
Long-term outcome of intravitreal anti-vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularization
T. Y. Y. Lai et al.
EYE (2012)
Comparison between One Injection and Three Monthly Injections of Intravitreal Bevacizumab for Myopic Choroidal Neovascularization
Yuichi Niwa et al.
OPHTHALMIC RESEARCH (2012)
NON-FULL-THICKNESS MACULAR HOLES REASSESSED WITH SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY
Zofia Michalewska et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2012)
INTRAVITREAL RANIBIZUMAB VERSUS BEVACIZUMAB FOR TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION
Pierluigi Iacono et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2012)
Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies
J. P. T. Higgins et al.
RESEARCH SYNTHESIS METHODS (2012)
Myopic choroidal neovascularization treated by intravitreal bevacizumab: comparison of two different initial doses
Jose M. Ruiz-Moreno et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2011)
Photodynamic monotherapy or combination treatment with intravitreal triamcinolone acetonide, bevacizumab or ranibizumab for choroidal neovascularization associated with pathological myopia
Pukhraj Rishi et al.
INDIAN JOURNAL OF OPHTHALMOLOGY (2011)
Myopic Choroidal Neovascularization
Jose M. Ruiz-Moreno et al.
OPHTHALMOLOGY (2011)
DIFFERENT DOSING OF INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION BECAUSE OF PATHOLOGIC MYOPIA
Taku Wakabayashi et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2011)
ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR MONOTHERAPY VERSUS COMBINATION TREATMENT WITH PHOTODYNAMIC THERAPY FOR SUBFOVEAL CHOROIDAL NEOVASCULARIZATION SECONDARY TO CAUSES OTHER THAN AGE-RELATED MACULAR DEGENERATION
Ling Chen et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2011)
Two-Year Visual Results for Older Asian Women Treated With Photodynamic Therapy or Bevacizumab for Myopic Choroidal Neovascularization
Yasushi Ikuno et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2010)
Choroidal Neovascularization in Pathologic Myopia: Intravitreal Ranibizumab Versus Bevacizumab-A Randomized Controlled Trial
Magda Gharbiya et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2010)
Laser Photocoagulation, Photodynamic Therapy, and Intravitreal Bevacizumab for the Treatment of Juxtafoveal Choroidal Neovascularization Secondary to Pathologic Myopia
Maurizio Battaglia Parodi et al.
ARCHIVES OF OPHTHALMOLOGY (2010)
Two-year comparison of photodynamic therapy and intravitreal bevacizumab for treatment of myopic choroidal neovascularisation
Takayuki Baba et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2010)
Bevacizumab for choroidal neovascularization secondary to pathologic myopia: Is there a decline of the treatment efficacy after 2 years?
Bogomil Voykov et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2010)
INTRAVITREAL ANTI-VEGF VERSUS PHOTODYNAMIC THERAPY WITH VERTEPORFIN FOR TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION
Jong Uk Yoon et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2010)
TWELVE-MONTH OUTCOME AFTER ONE INTRAVITREAL INJECTION OF BEVACIZUMAB TO TREAT MYOPIC CHOROIDAL NEOVASCULARIZATION
Jose M. Ruiz-Moreno et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2010)
The Effect of Hyperglycemia on Hypoperfusion-Induced Injury
Matthew C. Holman et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Intravitreal Bevacizumab vs Sub-Tenon Triamcinolone Acetonide for Choroidal Neovascularization Attributable to Pathologic Myopia
Taku Wakabayashi et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2009)
Comparison of Visual Outcome and Regression Pattern of Myopic Choroidal Neovascularization After Intravitreal Bevacizumab or After Photodynamic Therapy
Kengo Hayashi et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2009)
Photodynamic therapy with verteporfin for choroidal neovascularization of pathologic myopia in Japanese patients: Comparison with nontreated controls
Kengo Hayashi et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study
Wai-Man Chan et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2007)
Photodynamic therapy vs limited macular translocation in the management of subfoveal choroidal neovascularization in pathologic myopia: A two-year study
Agnes Glacet-Bernard et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
Last generation of amino-bisphosphonates (N-BPs) and cancer angiogenesis:: A new role for these drugs?
Daniele Santini et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2006)
Twofold illumination photodynamic therapy scheme for subfoveal choroidal neovascularization in pathologic myopia - Results from a randomized pilot study
Rogerio A. Costa et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2006)
Laser photocoagulation for choroidal neovascularisation in pathologic myopia
G. Virgili et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2005)
Photodynamic therapy of subfoveal recurrences after laser photocoagulation of extrafoveal choroidal neovascularization in pathologic myopia
F Bandello et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2003)
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia - 2-year results of a randomized clinical Trial - VIP report no. 3
KJ Blinder et al.
OPHTHALMOLOGY (2003)
Surgical treatment of subfoveal neovascularization in myopia: Macular translocation vs surgical removal
N Hamelin et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2002)
Radiotherapy for subfoveal neovascularisation associated with pathological myopia: A pilot study
H Kobayashi et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2000)
Share Paper
